Skip to main content

Together we are beating cancer

Donate now

Cancer News

Cancer type

Showing 12 out of 2908 results
Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

This entry is part 1 of 10 in the series Diversity in research
%postcontent%
Tissue stain of medulloblastoma - which is densely cellular and discrete from other tissue

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

by Lilly Matson | Analysis | 4 November 2022

4 November 2022

The House of Parliament in London

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

by Jacob Smith | Analysis | 1 November 2022

1 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact... A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact...

by Phil Prime | Interview | 27 September 2022

27 September 2022

A photograph of someone holding a test tube in a lab.

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma. We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

by Lilly Matson | Analysis | 22 September 2022

22 September 2022

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022